New medicines boosting health outcomes in Australia: report

24 June 2010

The publication of Australia's Health 2010 highlights the important contribution of prescription medicines in improving health outcomes for Australian patients, says the drug industry trade group Medicines Australia.

The report, published this week by the Australian Institute of Health and Welfare, outlines the impact of medicines and vaccines on a range of disease areas including HIV/AIDS, cardiovascular disease, cancer, and infectious diseases.

'This report demonstrates the importance of innovative new medicines in helping significantly to improve health outcomes across a number of diseases,' Brendan Shaw, chief executive of Medicines Australia, adding: 'We also see evidence that new medicines are helping keep patients out of hospital, which is particularly important where hospital costs are under increasing pressure.'

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Pharmaceutical